U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced
Primary HTS Code
3004.90.9190
$4641.1M monthly imports
Compare All →
Ruling Age
9 years
Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-04-29 · Updates monthly
The tariff classification of Metformin Hydrochloride Extended Release Tablets in dosage form, from India
N281147 December 2, 2016 CLA-2-30:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9190 Ms. Tanya Hurley Blue Point Laboratories 8 Eastgate Avenue Eastgate Business Park Little Island, Ireland RE: The tariff classification of Metformin Hydrochloride Extended Release Tablets in dosage form, from India Dear Ms. Hurley: In your letter dated November 8, 2016, you requested a tariff classification ruling. The subject product, Metformin Hydrochloride Extended Release Tablets in 1000 mg, is an antihyperglycemic drug. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The applicable subheading for the Metformin Hydrochloride Extended Release Tablets in dosage form will be 3004.90.9190, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at https://hts.usitc.gov/current. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at judy.h.lee@cbp.dhs.gov. Sincerely, Steven A. Mack Director National Commodity Specialist Division